Marco Taglietti
CIK 1408870 · Chief Executive Officer · last filed 2025-06-12
Marco Taglietti is a Chief Executive Officer who has filed 73 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for AQST, was dated Jun 12, 2025. Across all open-market trades the lifetime net is +$1.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.22M
5
73
$1.57M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AQST | Director | — | $4.17 | — | $0 | 6 | 2025-06-12 |
| SCYX | Chief Executive Officer | 272,068 | $4.23 | $1.15M | $2.13M | 35 | 2022-04-28 |
| DCTH | Director | 6,001 | $11.72 | $70.3K | $106.8K | 6 | 2020-05-08 |
| NephroGenex, Inc. (NRX) Delisted | Director | — | — | — | $0 | 2 | 2015-05-04 |
| Forest Laboratories, LLC (FRX) Delisted | EVP-Drug Dev & Ch.Medical Off. | 100,486 | $12.00 | $1.21M | -$663.9K | 23 | 2013-12-10 |
Recent Filings
73 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-12 | AQST | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | AQST | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | AQST | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | AQST | Grant (A) | — | $0 | EDGAR |
| 2022-04-28 | SCYX | Mixed | +75,000 | $225.0K | EDGAR |
| 2022-02-08 | SCYX | Grant (A) | +87,200 | $0 | EDGAR |
| 2021-06-17 | AQST | Grant (A) | — | $0 | EDGAR |
| 2021-03-15 | AQST | Grant (A) | — | $0 | EDGAR |
| 2021-02-02 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2020-12-23 | SCYX | Mixed | +40,000 | $250.0K | EDGAR |